CONNECT WITH US
eCommerce

eCommerce

Quarterly Checkup: The Top Takeaways From Beauty’s Q3 2026 Earnings Season

WWD logo

Published on

Add as a preferred source on Google
Quarterly Checkup: The Top Takeaways From Beauty’s Q3 2026 Earnings Season

Despite the ongoing challenges of the macroenvironment, it was good news for beauty companies, which continued to be buoyed by the rise of dermocosmetics and China's resurgence.

Beauty-makers are flexing in various categories and geographies. Here is a look at four major takeaways from the most recent quarterly earnings season, ended Sept. 30.

The dermocosmetics category, which sits at the crossroads of dermatology and traditional cosmetics, kept rising in importance for beauty companies in the third quarter of 2026.

At L’Oréal, the world’s biggest beauty company, the Dermatological Beauty division tied with the Professional Products division as the fastest grower in the three months ended Sept. 30, with an adjusted like-for-like sales rise of 13.9 percent.

Each of the three billionaire brands in the branch, La Roche-Posay, CeraVe and SkinCeuticals, grew by double digits.

“Dermocosmetics is an area of strategic focus for Puig, as reinforced with the recent announcement [of acquiring] the remaining 50 percent of Isdin,” said chief executive officer José Manuel Albesa, during a call with financial analysts and journalists, referencing the announcement the group made on Sept. 14 that it had agreed to take full ownership of the brand for 1.2 billion euros.

He described Isdin as being “at the forefront of skin care, photoprotection and photoaging, rooted in medical credibility” and an important step in Puig’s long-term strategy.

Puig believes dermocosmetics will be skin care’s fastest-growing category in the years to come. In the third quarter, the category, led by the group’s Uriage brand, continued delivering double-digit gains.


Source link

Disclaimer

We strive to uphold the highest ethical standards in all of our reporting and coverage. We TheMorningPulse.fyi want to be transparent with our readers about any potential conflicts of interest that may arise in our work. It's possible that some of the investors we feature may have connections to other businesses, including competitors or companies we write about. However, we want to assure our readers that this will not have any impact on the integrity or impartiality of our reporting. We are committed to delivering accurate, unbiased news and information to our audience, and we will continue to uphold our ethics and principles in all of our work. Thank you for your trust and support.